curcumin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases visual analogue scale pain intensity
PreliminaryGrade D, Preliminary. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The NMA results showed that compared with placebo, curcumin significantly reduced the visual analogue scale pain score (MD = -1.63, 95% CI: -2.91 to -0.45) and total WOMAC score (MD = -18.85, 95% CI: -29.53 to -8.76).”
Quoted verbatim from Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.. - Study
- meta-analysis
- Population
- Patients with knee osteoarthritis; Bayesian network meta-analysis, the contrast recorded here is curcumin monotherapy versus placebo. The review included 23 studies and 2175 KOA patients across 6 interventions overall; the abstract does not state how many patients or trials fed this particular pairwise estimate. The abstract does not state the VAS anchors, the scale length, or the recall frame.
Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.2024PMID:38036015Permalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against Visual analogue scale pain intensity
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3R2J1BP9DVZJT7AQ422ZCKR